📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: iSpecimen

1.1 - Company Overview

iSpecimen Logo

iSpecimen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of an online marketplace connecting researchers to millions of human biospecimens and patients across a global network of providers, streamlining specimen procurement. Offers diagnostic remnant, banked, and prospectively collected samples, including biofluids with associated test and clinical data, tissue with clinical/molecular annotation, stem and immune cells with donor attribute options, and matched sets.

Products and services

  • Biofluids: Offers various blood and non-blood biofluids accompanied by associated test and clinical data, data-linked, supporting research requiring samples paired with precise clinical and assay information
  • ISpecimen Marketplace: Delivers streamlined specimen procurement by enabling access to millions of human biospecimens and patients across a global network of providers, global-scale, consolidating sourcing into a single online platform
  • Tissue Samples: Supplies a wide range of disease-state tissue samples, many with clinical and molecular annotation, molecularly annotated, supporting studies requiring annotated tissues across diverse conditions and states

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to iSpecimen

Ion Torrent Logo

Ion Torrent

HQ: United States Website
  • Description: Provider of sequencing technology that enables a direct connection between chemical and digital information; the first commercial PostLight sequencing technology that doesn't use light. Ion Torrent is a wholly-owned subsidiary of Life Technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ion Torrent company profile →
Proteos Logo

Proteos

HQ: United States Website
  • Description: Provider of contract research services specializing in recombinant protein expression and purification to support drug discovery in the biotechnology and pharmaceutical industries.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Proteos company profile →
Miromatrix Logo

Miromatrix

HQ: United States Website
  • Description: Provider of fully biological human organs and organ-derived products to address the transplant shortage, using patented perfusion decellularization/recellularization technology, plus PAH therapy and patient support via Remodulin (IV/SC), ASSIST, Archways for inhaled/oral treprostinil, and an Expanded Access Program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Miromatrix company profile →
Neothetics Logo

Neothetics

HQ: United States Website
  • Description: Provider of clinical-stage specialty pharmaceutical therapeutics for the aesthetic market.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neothetics company profile →
Perfectus Biomed Logo

Perfectus Biomed

HQ: United Kingdom Website
  • Description: Provider of U.K.-based microbiological services with a research-driven approach to testing, rapid turnaround, and personalized service, specializing in bespoke assays and biofilm testing. Offers biological safety consulting, clinical research for medical devices, IVD services, product development strategy, quality and regulatory consulting, and the NAMSA APEX Program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Perfectus Biomed company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for iSpecimen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to iSpecimen

2.2 - Growth funds investing in similar companies to iSpecimen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for iSpecimen

4.2 - Public trading comparable groups for iSpecimen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to iSpecimen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About iSpecimen

What does iSpecimen do?

iSpecimen is a provider of an online marketplace connecting researchers to millions of human biospecimens and patients across a global network of providers, streamlining specimen procurement. Offers diagnostic remnant, banked, and prospectively collected samples, including biofluids with associated test and clinical data, tissue with clinical/molecular annotation, stem and immune cells with donor attribute options, and matched sets.

Who are iSpecimen's competitors?

iSpecimen's competitors and similar companies include Ion Torrent, Proteos, Miromatrix, Neothetics, and Perfectus Biomed.

Where is iSpecimen headquartered?

iSpecimen is headquartered in United States.

How many employees does iSpecimen have?

iSpecimen has 1,000 employees 🔒.

When was iSpecimen founded?

iSpecimen was founded in 2010 🔒.

What sector and industry vertical is iSpecimen in?

iSpecimen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for iSpecimen

Who are the top strategic acquirers in iSpecimen's sector and industry

Top strategic M&A buyers and acquirers in iSpecimen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for iSpecimen?

Top strategic M&A buyers groups and sectors for iSpecimen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in iSpecimen's sector and industry vertical

Which are the top PE firms investing in iSpecimen's sector and industry vertical?

Top PE firms investing in iSpecimen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in iSpecimen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in iSpecimen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in iSpecimen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to iSpecimen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in iSpecimen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for iSpecimen?

The key public trading comparables and valuation benchmarks for iSpecimen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for iSpecimen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for iSpecimen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in iSpecimen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for iSpecimen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in iSpecimen's' sector and industry vertical?

Access recent funding rounds and capital raises in iSpecimen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for iSpecimen

Launch login modal Launch register modal